Skip to content
TrackPodcasts
educationNov 13, 202514:37pending

Discussing axSpA: Adalimumab dosing and uveitis recurrence in patients with ankylosing spondylitis

The IMID Forum

About this episode

Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered the Association between adalimumab dosing interval and uveitis recurrence in patients with ankylosing spondylitis.

Get every episode summarized

Each time The IMID Forum publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

Discussing axSpA: Adalimumab dosing and uveitis recurrence in patients with ankylosing spondylitis

The IMID Forum

0:00
14:37

More episodes

More from The IMID Forum

View all episodes →